Skip to main content
. 2017 Aug 30;10:434. doi: 10.1186/s13104-017-2754-y

Table 1.

Direct costs per TB case in the US, by cost component, adjusted to 2015 dollars

Ref. Type of TB Setting, US state(s) Sample year(s) Sample size Hospitalization Physician fees, inpatient Physician fees, outpatient Outpatient case management Laboratory and imaging tests Medications
[20] Drug-susceptible 16 statesa 1990 n/s 26,900b 3800 6200
MDR 21,500
[21] Drug-susceptible IA 1991 n/a 10,100 600 2200 800
[14] Drug-susceptible CA, MS, NJ 1992 178 1600 1200
[22] Drug-susceptible PA 1992 18 45,400
[23] Drug-susceptible MD 1992–94 n/s 600 3100 1200 1300
[24] Drug-susceptible MA 1993 n/a 1300
MDR 16,900
[25] Drug-susceptible IL 1993–94 90 3400 1300
[5] Drug-susceptible CA 1995 300
MDR CA 1995 1200
[10] Drug-susceptible 7 statesc 1995–96 733 19,300
[26] MDR 7 statesc 1995–96 13 43,300 4000 34,100
[8] Drug-susceptible US 2006 8800 18,300b
[27] Drug-susceptible OR 2006 42 8000
[28] MDR CA, NY, TX 2005–07 130 62,600
[6] Drug-susceptible NC 2008–10 99 1400 1400 300
[29] MDR US 2009 n/a 11,600
[30] Drug-susceptible TN 2010 n/a 2900 500
[4] Drug-susceptible US 2011 n/a 200
[31] Drug-susceptible US 2014 n/a 300

n/s not specified, n/a not applicable (i.e., estimates not based on a sample of cases, but on administrative data)

aAZ, CA, CO, FL, MA, ME, NH, NJ, NV, NY, OR, PA, SC, VT, WA, WI

bThe reported value was per hospitalization episode, and was adjusted to a per-case patient estimate using the utilization assumptions detailed in Additional file 3

cCA, GA, IL, MS, NY, SC, TX